Skip to content

Clinical study of nabulphine combined with dexmedetomidine in improving maternal comfort during cesarean section

Clinical study of nabulphine combined with dexmedetomidine in improving maternal comfort during cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070689
Enrollment
Unknown
Registered
2023-04-20
Start date
2023-04-20
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Study on comfort during cesarean section

Interventions

ND group: Nalbuphine combined with dexmedetomidine group:Intravenous nalbuphine + dexmedetomidine pump
N group: nabulphine group:Intravenous Nalbuphine + dexmedetomidine pump,
Group D: dexmedetomidine group:Intravenous normal saline + dexmedetomidine pump

Sponsors

Taizhou People's Hospital Affiliated to Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA grade I and II; Age: 20 ~ 40 years old; BMI between 19 and 39kg/ m2; The maternal sign the informed consent voluntarily; Preoperative routine examination showed no obvious abnormality. No contraindications to lumbar epidural anesthesia; Operation time 37 weeks.

Exclusion criteria

Exclusion criteria: The blocking level exceeds T4 or is less effective; Sinus bradycardia; Allergies to the drugs used in this study; A history of chronic pain, long-term use of opioid analgesics or NSaids; Intraoperative blood loss greater than 800mL; Suffering from mental illness.

Design outcomes

Primary

MeasureTime frame
Occurrence of intraoperative nausea and vomiting;Traction response grading;Grading of chills reaction;Intraoperative Ramsay Sedation score;

Secondary

MeasureTime frame
Incision pain at rest 24 hours after operation;Tocodynia at rest;Incision pain during exercise;VAS pain scores for tocolytic pain during exercise;Qor40 score on postoperative day;sleep quality;Comfort score;IL-6 and CRP levels;Lactation initiation time;Lactation volume score;Postoperative adverse effects;

Countries

China

Contacts

Public ContactJiangbingxue

Taizhou People's Hospital Affiliated to Nanjing Medical University

349069724@qq.com+86 15844491989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026